@article{f105df1a540a4064abca418dcc2dd3fb,
title = "Long-term Outcome of Implantable Cardioverter/Defibrillator Lead Failure",
author = "Davidsson, \{Gustav Arnar\} and Jonsdottir, \{Gudlaug M.\} and Hjortur Oddsson and Lund, \{Sigrun H.\} and Arnar, \{David O.\}",
note = "Funding Information: (German Center for Infection Research) outside the submitted work. Dr Cornely reported grants from Janssen, The Medicines Company, Medpace, Melinta, Merck, Pfizer, and Scynexis and personal fees from Matinas, Medpace, Menarini, Merck, Paratek, Pfizer, PSI, Rempex, Scynexis, Seres, Tetraphase, Octapharma, Biosys, Allecra, Entasis, and Grupo Biotoscana, outside the submitted work. Dr Vehreschild reported grants and personal fees from Merck/ MSD, Gilead, Pfizer, Astellas Pharma, Basilea, Deutsches Zentrum f{\"u}r Infektionsforschung, personal fees from Uniklinik Freiburg/Kongress und Kommunikation, Akademie f{\"u}r Infektionsmedizin, Universit{\"a}t Manchester, Deutsche Gesellschaft f{\"u}r Infektiologie, {\"A}rztekammer Nordrhein, Uniklinik Aachen, Back Bay Strategies, Deutsche Gesellschaft f{\"u}r Innere Medizin, and grants from Bundesministerium f{\"u}r Bildung und Forschung outside the submitted work. No other disclosures were reported.",
year = "2020",
month = feb,
doi = "10.1001/jamainternmed.2019.4717",
language = "English",
volume = "180",
pages = "322--324",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "2",
}